Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Allogenic thymocyte-depleted thymus tissue-agdc
Medication labelRETHYMIC® is indicated for immune reconstitution in pediatric patients with congenital athymia. Limitations of Use RETHYMIC is not indicated…
Why this: Advisory · dailymed-prescription
RETHYMIC® is indicated for immune reconstitution in pediatric patients with congenital athymia. Limitations of Use RETHYMIC is not indicated for the treatment of patients with severe combined immunodeficiency (SCID).
- generic_name
- allogenic thymocyte-depleted thymus tissue-agdc
- product_names
- allogenic thymocyte-depleted thymus tissue-agdc
- ndc
- 72359-001, 72359-001-02, 72359-001-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en